DEFA1 and Alzheimer disease: In contrast, we observed higher NPX of DEFA1 protein in carriers of the ABCA7 variant, which is consistent with previous studies showing higher levels of this protein in cerebral spinal fluid (CSF) and sera of AD patients compared to controls45,46, potentially linking ABCA7 with an inflammatory response pathway to AD.